Trial Outcomes & Findings for Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease (NCT NCT01854242)
NCT ID: NCT01854242
Last Updated: 2020-07-28
Results Overview
Participants who tested positive for Crohn disease, ulcerative colitis, or unspecified inflammatory bowel disease (IBD) on a panel for IBD are reported in the Outcome Measure Data Table.
Recruitment status
COMPLETED
Target enrollment
50 participants
Primary outcome timeframe
2 weeks
Results posted on
2020-07-28
Participant Flow
Participant milestones
| Measure |
Glycogen Storage Disease Type Ia Patients
The participants will have one blood draw for this study. The test will be performed on the blood.
|
|---|---|
|
Overall Study
STARTED
|
50
|
|
Overall Study
COMPLETED
|
50
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease
Baseline characteristics by cohort
| Measure |
Glycogen Storage Disease Type Ia Patients
n=50 Participants
The participants will have one blood draw for this study. The test will be performed on the blood.
|
|---|---|
|
Age, Categorical
<=18 years
|
32 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
18 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
23 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
27 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
50 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 2 weeksParticipants who tested positive for Crohn disease, ulcerative colitis, or unspecified inflammatory bowel disease (IBD) on a panel for IBD are reported in the Outcome Measure Data Table.
Outcome measures
| Measure |
Glycogen Storage Disease Type Ia Patients
n=50 Participants
The participants will have one blood draw for this study. The test will be performed on the blood.
|
|---|---|
|
Serologic, Genetic and Inflammatory Markers Consistent With Inflammatory Bowel Disease
|
11 participants testing positive
|
Adverse Events
Glycogen Storage Disease Type Ia Patients
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place